(Q33996838)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10934349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

Targeting drugs to the brain by redox chemical delivery systems (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10934349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10934349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

K Prokai-Tatrai

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10934349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

N Bodor

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10934349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10934349%20AND%20SRC:MED&resulttype=core&format=json

Medicinal Research Reviews

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10934349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10934349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10934349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

367-416

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10934349%20AND%20SRC:MED&resulttype=core&format=json

The Anatomy of the Blood Brain Barrier: A Review

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Junctions between intimately apposed cell membranes in the vertebrate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Permeability changes in the blood-brain barrier: causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Inhibition of dipeptide transport in mouse brain slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Receptor-mediated peptide transport through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Peptidases, peptides, and the mammalian blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Cancer chemotherapy: alternative routes of drug administration. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Beta-endorphin chimeric peptides: transport through the blood-brain barrier in vivo and cleavage of disulfide linkage by brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Site-specific, sustained release of drugs to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Problems of delivery of drugs to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Improved delivery through biological membranes. 11. A redox chemical drug-delivery system and its use for brain-specific delivery of phenylethylamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Physiological roles of nicotinamide nucleotide transhydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Elimination of a Quaternary Pyridinium Salt Delivered as Its Dihydropyridine Derivative from Brain of Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Improved delivery through biological membranes. 1. Synthesis and properties of 1-methyl-1,6-dihydropyridine-2-carbaldoxime, a pro-drug of N-methylpyridinium-2-carbaldoxime chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Improved delivery through biological membranes. 3. Delivery of N-methylpyridinium-2-carbaldoxime chloride through the blood-brain barrier in its dihydropyridine pro-drug form

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Improved delivery through biological membranes XIX: Novel redox carriers for brain-specific chemical delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Improved delivery through biological membranes XX: Nicotinamide----dihydronicotinamide based ester-linked redox carrier systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Brain-specific chemical delivery systems for beta-lactam antibiotics. Synthesis and properties of some dihydropyridine and dihydroiosquinoline derivatives of benzylpenicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Spontaneous reactions of 1,3-substituted 1,4-dihydropyridines with acids in water at neutrality. II. Nuclear magnetic resonance studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Neurobiology of L-DOPAergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Redox delivery system for brain-specific, sustained release of dopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Direct evidence for brain-specific release of dopamine from a redox delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Evaluation of isonicotinoyl-gamma-aminobutyric acid (GABA) and nicotinoyl-GABA as pro-drugs of GABA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Antihypertensive activity of redox derivatives of tryptophan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Concomitant changes in cyclic AMP level and postsynaptic potentials of olfactory cortex slices induced by adenosine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Purine receptors in mammalian tissues: pharmacology and functional significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Oral contraceptives, lipids and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Cardiovascular Complications of Oral Contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Multiple dopamine receptors and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Atlas of estradiol-concentrating cells in the central nervous system of the female rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Neural Regulation of Luteinizing Hormone Secretion in the Rat*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

The Role of Catecholamines in the Regulation of Pituitary Luteinizing Hormone and Follicle-Stimulating Hormone Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Intrahypothalamic Implants of Testosterone or Estradiol and Resumption of Masculine Sexual Behavior in Long-term Castrated Male Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Neural gonadal steroid actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Role of female gonadal hormones in the CNS: clinical and experimental aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Improved delivery through biological membranes. 32. Synthesis and biological activity of brain-targeted delivery systems for various estradiol derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

High-performance liquid chromatographic assay of a central nervous system (CNS)-directed estradiol chemical delivery system and its application after intravenous administration to rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

A redox-based chemical delivery system that enhances estradiol distribution to the brain: disposition studies in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

A redox-based system that enhances delivery of estradiol to the brain: pharmacokinetic evaluation in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Dose and time-course evaluation of a redox-based estradiol-chemical delivery system for the brain. I. Tissue distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

A novel redox system for CNS-directed delivery of estradiol causes sustained LH suppression in castrate rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Sustained brain-specific delivery of estradiol causes long-term suppression of luteinizing hormone secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Evidence for suppression of serum LH without elevation in serum estradiol or prolactin with a brain-enhanced redox delivery system for estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

A redox system for brain targeted estrogen delivery causes chronic body weight decrease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Chronic weight loss in lean and obese rats with a brain-enhanced chemical delivery system for estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Effects of a brain-enhanced chemical delivery system for estradiol on body weight and serum hormones in middle-aged male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Effects of a brain-enhanced chemical delivery system for estradiol on body weight and food intake in intact and ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Growth hormone (GH) secretory dynamics in animals administered estradiol utilizing a chemical delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

The Effects of a Brain-Enhanced Estradiol Delivery System on Testosterone and Androgen-Dependent Tissues. I. Dose-Response and Time-Course Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Brain-targeted delivery of estrogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Improved Delivery Through Biological Membranes. XXIV. Synthesis, in Vitro Studies, and in Vivo Characterization of Brain-Specific and Sustained Progestin Delivery Systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

A model for quantitation of peritumoral brain edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Effects of dexamethasone on tumor-induced brain edema and its distribution in the brain of monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Effect of a chemical delivery system for dexamethasone (Dex-CDS) on peritumoral edema in an experimental brain tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

The AIDS dementia complex: II. Neuropathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

The neuropathology of the acquired immune deficiency syndrome (AIDS). A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Restricted transport of 3'-azido-3'-deoxythymidine and dideoxynucleosides through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of dihydropyridine derivatives of 3'-azido-2',3'-dideoxyuridine and 3'-azido-3'-deoxythymidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Brain, Blood, and Cerebrospinal Fluid Distribution of a Zidovudine Chemical Delivery System in Rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

AIDS dementia: synthesis and properties of a derivative of 3'-azido-3'-deoxythymidine (AZT) that may become 'locked' in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

The biochemistry and mechanism of action of acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Direct cerebrospinal fluid delivery of an antiretroviral agent using multivesicular liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Chemotherapy for 'exotic' RNA viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Ribavirin: An antiviral agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Susceptibility of Gram-Positive Cocci to Various Antibiotics, Including Cefotaxime, Moxalactam, and N -Formimidoyl Thienamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Treatment of intracranial dengue virus infections in mice with a lipophilic derivative of ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Effect of ribavirin and tributylribavirin on argentine hemorrhagic fever (Junin virus) in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Hydroxylation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) by rat liver microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Improved delivery through biological membranes. XLV. Synthesis, physical-chemical evaluation, and brain uptake studies of 2-chloroethyl nitrosourea delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Status epilepticus at an urban public hospital in the 1980s

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Advances in the medical treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Independent blood-brain barrier transport systems for nucleic acid precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Esters of Hydantoic Acids as Prodrugs of Hydantoins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Distribution of valproate across the interface between blood and cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Chemical delivery systems for some penicillinase-resistant semisynthetic penicillins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

In vitro and in vivo investigations of dihydropyridine-based chemical delivery systems for anticonvulsants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Synthesis, biological evaluation, calcium channel antagonist activity, and anticonvulsant activity of felodipine coupled to a dihydropyridine-pyridinium salt redox chemical delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Behavioural despair in rats: A new model sensitive to antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Redox derivatives of tranylcypromine: syntheses, properties, and monoamine oxidase inhibitor activity of some chemical delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Antibiotic penetration of the brain. A comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

The penetration of antibiotics into cerebrospinal fluid and brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Application of a brain-targeting chemical delivery system to 9-amino-1,2,3,4-tetrahydroacridine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Sulfadiazine-induced multiple urolithiasis and acute renal failure in a patient with AIDS and Toxoplasma encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

The antioxidant LY231617 reduces global ischemic neuronal injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

A strategy for delivering peptides into the central nervous system by sequential metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Brain-targeted delivery of a leucine-enkephalin analogue by retrometabolic design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Novel agents affecting enkephalinergic and histaminergic transmissions in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Isolation of thyrotropin releasing factor (TRF) from porcine hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin-releasing hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

An update on the CNS actions of TRH and its analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Metabolism-based brain-targeting system for a thyrotropin-releasing hormone analogue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Mechanism of C-terminal amide formation by pituitary enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Unusual secondary specificity of prolyl oligopeptidase and the different reactivities of its two forms toward charged substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Strategies to target kyotorphin analogues to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

Central noradrenergic neurones concentrate 3H-oestradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200009%2920%3A5%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-P

10.1002/1098-1128(200009)20:5<367::AID-MED3>3.0.CO;2-P

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10934349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference